Article PDF
References
Hager, J. et al. Nature Genet 9, 299–304 (1995).
Gough, S.C.L. et al. Hum. Mol. Genet. 4, 1609–1612 (1995).
Modan, M. et al. J. Clin. Invest. 75, 809–817 (1985).
Reaven, G.M. & Hoffman, B.B. Am. J. Med. 87, 2–68 (1989).
Allemann, Y. et al. Lancet 341, 327–331 (1993).
Morris, B.J. et al. J. Clin. Invest. 94, 1085–1089 (1994).
Stern, N. & Tuck, M.L. . in Hypertension: Pathophysiology, Diagnosis and Management (eds Laragh, J.H. & Brenner, B.M.) 2301–2314 (Raven Press, New York, 1995).
Hansen, L. et al. Diabetes(in the press).
Kawai, K. et al. 38, 274–276 (1995).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Chambers, S., Morris, B. Glucagon receptor gene mutation in essential hypertension. Nat Genet 12, 122 (1996). https://doi.org/10.1038/ng0296-122
Issue Date:
DOI: https://doi.org/10.1038/ng0296-122
This article is cited by
-
Genetics of salt-sensitive hypertension
Current Hypertension Reports (2007)
-
Neuropeptide gene polymorphisms and human behavioural disorders
Nature Reviews Drug Discovery (2003)
-
Analysis of Gly40Ser polymorphism of the glucagon receptor (GCGR) gene in different ethnic groups
Journal of Human Hypertension (2003)
-
Critique of “Chromosome 17 and the inducible nitric oxide synthase gene in human essential hypertension” by Rutherford et al., Human Genetics, published online September 2001
Human Genetics (2002)
-
Gly40Ser Polymorphism of the Glucagon Receptor Gene Is Associated with Central Adiposity in Men
Obesity Research (2001)